Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-STC1 Polyclonal Antibody

Catalog #:   PHE95601 Specific References (38) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: P52823
Overview

Catalog No.

PHE95601

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Human STC1 (Ser28-Ala247).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

STC1,Stanniocalcin-1,STC,STC-1

Purification

Purified by antigen affinity column.

Accession

P52823

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • WESTERN BLOT
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with STC1 antibody (PHE95601) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 52 kDa
    Observed MW: 52 kDa
References

Hypoxia Microenvironment Preconditioning Attenuated Myocardial Ischemia-Reperfusion Injury via Stc1-Mediating Cardiomyocyte Self-Protection and Neutrophil Polarization., PMID:39676707

FVIIa-PAR2 signaling facilitates immune escape by reducing phagocytic potential of macrophages in breast cancer., PMID:39667690

Imaging flow cytometry reveals LPS-induced changes to intracellular intensity and distribution of α-synuclein in a TLR4-dependent manner in STC-1 cells., PMID:39486562

A Newly Developed Anti-L1CAM Monoclonal Antibody Targets Small Cell Lung Carcinoma Cells., PMID:39201435

CircUBA2 promotes the cancer stem cell-like properties of gastric cancer through upregulating STC1 via sponging miR-144-5p., PMID:39103836

Biosensors Based on Stanniocalcin-1 Protein Antibodies Thin Films for Prostate Cancer Diagnosis., PMID:37998156

Analysis of the benefit of salvage chemotherapy after progression on nivolumab in patients with squamous cell carcinoma of the head and neck., PMID:37562096

Emerging phagocytosis checkpoints in cancer immunotherapy., PMID:36882399

Serum Autoantibodies against LRDD, STC1, and FOXA1 as Biomarkers in the Detection of Ovarian Cancer., PMID:35273656

Stanniocalcin 1 is a serum biomarker and potential therapeutic target for HBV-associated liver fibrosis., PMID:35122667

Stanniocalcin-1 protein expression profile and mechanisms in proliferation and cell death pathways in prostate cancer., PMID:31816356

Stanniocalcin 1 in tumor microenvironment promotes metastasis of ovarian cancer., PMID:31114228

Endothelial Stanniocalcin 1 Maintains Mitochondrial Bioenergetics and Prevents Oxidant-Induced Lung Injury via Toll-Like Receptor 4., PMID:30187766

The EndoC-βH1 cell line is a valid model of human beta cells and applicable for screenings to identify novel drug target candidates., PMID:29307512

Secretory Stanniocalcin 1 promotes metastasis of hepatocellular carcinoma through activation of JNK signaling pathway., PMID:28688970

Nicotine-Induced Effects on Nicotinic Acetylcholine Receptors (nAChRs), Ca2+ and Brain-Derived Neurotrophic Factor (BDNF) in STC-1 Cells., PMID:27846263

STC-1 expression is upregulated through an Akt/NF-κB-dependent pathway in triple-negative breast cancer cells., PMID:27461417

A novel anti-inflammatory role of GPR120 in intestinal epithelial cells., PMID:26791484

The oncogenetic role of stanniocalcin 1 in lung adenocarcinoma: a promising serum candidate biomarker for tracking lung adenocarcinoma progression., PMID:26577859

Severe Nephrotoxic Nephritis following Conditional and Kidney-Specific Knockdown of Stanniocalcin-1., PMID:26393521

GLP-1 amidation efficiency along the length of the intestine in mice, rats and pigs and in GLP-1 secreting cell lines., PMID:24486427

Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity., PMID:23982491

Expression of stanniocalcin-1 in culprit coronary plaques of patients with acute myocardial infarction or stable angina., PMID:23757035

Effects of somatostatin and octreotide on the interactions between neoplastic gastroenteropancreatic endocrine cells and endothelial cells: a comparison between in vitro and in vivo properties., PMID:21677423

Stanniocalcin-1 promotes tumor angiogenesis through up-regulation of VEGF in gastric cancer cells., PMID:21672207

Human stanniocalcin-1 interacts with nuclear and cytoplasmic proteins and acts as a SUMO E3 ligase., PMID:21042649

Human marrow-isolated adult multilineage-inducible (MIAMI) cells protect against peripheral vascular ischemia in a mouse model., PMID:20839998

Stanniocalcin 1 and ovarian tumorigenesis., PMID:20484106

The corpuscles of Stannius, calcium-sensing receptor, and stanniocalcin: responses to calcimimetics and physiological challenges., PMID:19299449

Anti-inflammatory and renal protective actions of stanniocalcin-1 in a model of anti-glomerular basement membrane glomerulonephritis., PMID:19246645

Multimodal imaging for the detection and characterization of liver lesions in a mouse model of neuroendocrine tumor., PMID:18341975

Passive immunization of lactating mice with stanniocalcin-1 antiserum reduces mammary gland development, milk fat content, and postnatal pup growth., PMID:16772321

A novel approach in the treatment of neuroendocrine gastrointestinal tumours. Targeting the epidermal growth factor receptor by gefitinib (ZD1839)., PMID:14583782

Stanniocalcin 1 is an autocrine modulator of endothelial angiogenic responses to hepatocyte growth factor., PMID:14500721

Pancreatic phospholipase A2 from the small intestine is a secretin-releasing factor in rats., PMID:11447033

GABA(C) receptors in neuroendocrine gut cells: a new GABA-binding site in the gut., PMID:11211116

Gastric inhibitory polypeptide release from a tumor-derived cell line., PMID:7653549

[Generation of effector cells from primary lung cancer patients by stimulation with anti-CD3 monoclonal antibody followed by culture with recombinant interleukin-2]., PMID:1484432

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-STC1 Polyclonal Antibody [PHE95601]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only